BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2014 2:41:00 PM | Browse: 940 | Download: 905
|
Received |
|
2013-10-07 15:22 |
|
Peer-Review Started |
|
2013-10-08 09:12 |
|
To Make the First Decision |
|
2013-12-16 17:59 |
|
Return for Revision |
|
2013-12-17 11:10 |
|
Revised |
|
2013-12-27 00:37 |
|
Second Decision |
|
2014-01-20 18:34 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2014-01-20 19:13 |
|
Articles in Press |
|
|
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-03-23 19:48 |
|
Publish the Manuscript Online |
|
2014-04-14 10:49 |
Category |
Oncology |
Manuscript Type |
Topic Highlights |
Article Title |
Treatment options in patients with metastatic gastric cancer: Current status and future perspectives
|
Manuscript Source |
Invited Manuscript |
All Author List |
Ahmet Bilici |
Funding Agency and Grant Number |
|
Corresponding Author |
Ahmet Bilici, MD, Department of Medical Oncology, Medical Faculty, Istanbul Medipol University, TEM Avrupa Otoyolu Goztepe Cikisi No: 1, Bagcilar, 34214 Istanbul, Turkey. ahmetknower@yahoo.com |
Key Words |
Gastric cancer; Chemotherapy; Targeted therapy; Metastasis; Advanced-stage |
Core Tip |
Although palliative chemotherapy have been demonstrated to improve survival and quality of life, the prognosis of patients with metastatic gastric cancer remains poor and responses to first-line chemotherapy are partial and heterogeneous. In order to improve the results of currently available treatments, remarkable advancements in new targeted agents have recently been obtained. The addition of trastuzumab to cisplatin/fluoropyrimidine-based chemotherapy significantly improved survival in patients with human epidermal growth factor receptor 2-positive metastatic gastric cancer, which is now the new standard of care. Our manuscript will elucidate current systemic chemotherapy and promising targeted therapies for metastatic gastric cancer in the first- and second-line setting in the light of recent advances. |
Publish Date |
2014-04-14 10:49 |
Citation |
Bilici A. Treatment options in patients with metastatic gastric cancer: Current status and future perspectives. World J Gastroenterol 2014; 20(14): 3905-3915 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i14/3905.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i14.3905 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345